NURECANSENureca LimitedHighNegative
Announced Fri, 29 May · 20:24 IST

Nureca Limited has informed the Exchange regarding Resignation of Naresh Gupta as Chief Financial Officer of the company w.e.f. Jun 26, 2026.

Cfo ResignedPromoter Family Board EntryManagement Changes View source PDF

NURECA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-15.3%1-day move
₹281.25
prior close
₹232.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.5+2.5+4.6+4.5-15.3-16.4-16.8-15.9-18.2-18.9-15.4-16.3
Up moveDown movePending
AI summary

Nureca Limited's Board meeting on May 29, 2026 addressed multiple items. Mr. Naresh Gupta resigned as CFO effective June 26, 2026 citing better career opportunities, and Mr. Chander Kant (previously Manager Finance) was promoted to CFO effective June 27, 2026. The company reported FY26 revenue of Rs 1,472.10 million (up 28% YoY) with profit after tax of Rs 2.97 million, though Q4 saw a loss of Rs 66.25 million due to Rs 83.37 million fair value loss on investments. Three Goyal family members were reappointed or newly appointed to key director roles: Mr. Aryan Goyal (CEO), Mr. Saurabh Goyal (MD), and Ms. Smita Goyal (sister-in-law/spouse of the other two) as Additional WTD. The board approved Rs 100 crore capex for manufacturing expansion at Derabassi, Punjab. A share buyback at Rs 330/share was completed in Q3 FY26.

Likely market impact

The CFO transition appears smooth with an internal replacement, but the appointment of three related family members to the board raises governance concerns. Strong FY26 revenue growth is positive, though Q4 losses from investment mark-to-market warrant monitoring.